Prepared by Dr. Anna Kowalski, CFA, Senior Equity Strategist | Reviewed by Marcus Thorne, Lead Editor | Report ID: IGEMINI-15CA6BA7-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of cardinal health stock reveals a Cautiously Constructive configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 15.71 EPS and a 0.36% yield. Institutional flows indicate 66% ownership with beta of 1.26.
Rating: Outperform | Target Price: $1481.74 | Next Earnings: Jun 28
Download Full PDF Report
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
On-chain money flow shows 23%% increase in smart money index, reinforcing the technical setup.
Price action carved a Inverse Head and Shoulders, confirmed by a 1.51x volume spike on May 28, 2026. The resistance at $1172.6 was tested.
EPS of $15.71 reveals resilient earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
Free cash flow conversion remains robust at 77%, supporting the 0.36% dividend and buybacks.
Relative to Technology peers, cardinal health stock sits at the 63th percentile in valuation, offering a potential value opportunity.
Beta of 1.26 suggests cardinal health stock is {beta_desc} volatile than the market, influencing hedging strategies.
Short float at 3.1% is below the sector average, reducing squeeze risk. Institutional ownership is 66%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1066 | $1012.7 |
| Market Cap | $24.8B | $19.84B |
| P/E Ratio | 67.87x | 57.7x |
| EPS (TTM) | $15.71 | $14.14 |
| Dividend Yield | 0.36% | 0.3% |
| Revenue Growth | 33.5% | 20.1% |
| Target Price | $1481.74 | - |
| Beta | 1.26 | 1.00 |